
|Videos|December 13, 2022
Baxter BioPharma Solutions Continues to Expand its Manufacturing Capacity
Author(s)Baxter BioPharma Solutions
KEY LEARNING OBJECTIVES
- It’s an exciting time for us at BPS – We are expanding at both contract manufacturing locations
- We have a proven track record of being able to execute on our commitments
- Learn how customers can get in touch with BPS
Trending on Pharmaceutical Technology
1
Why Big Pharma Is Betting Billions on Protein Degraders for Cancer
2
GSK Acquires Nuvalent for $10.6 Billion in Lung Cancer Push
3
USP Reports Drug Discontinuations on the Rise
4
Enhancing Clinical Data Infrastructure for AI Research: A Strategic Guide for Pharma Professionals
5




